Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System
Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System
Source: itnewsonline.com
Stay updated with breaking news from Vicky Pirzas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System
Blood Money | After Paul Perreault grew CSL revenue by $US5 billion and profit by $US1 billion, the pressure is on new CEO Paul McKenzie to keep up the growth.